Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Litzroth A, Suin V, Wyndham-Thomas C, Quoilin S, Muyldermans G, Vanwolleghem T, Kabamba-Mukadi B, Verburgh V, Jacques M, Van Gucht S, Hutse V.
Litzroth A, et al.
BMC Public Health. 2019 Jan 8;19(1):39. doi: 10.1186/s12889-018-6347-z.
BMC Public Health. 2019.
PMID: 30621662
Free PMC article.